These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7976360

  • 1. [Study on mitoxantrone polycyanoacrylate nanospheres].
    Zhang ZR, Liao GT, Hou SX.
    Yao Xue Xue Bao; 1994; 29(7):544-9. PubMed ID: 7976360
    [Abstract] [Full Text] [Related]

  • 2. [Study on pharmacokinetics of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection by HPLC column switching technique].
    Zhang ZR, Liao GT, Ye LM.
    Yao Xue Xue Bao; 1995 Nov; 30(11):843-7. PubMed ID: 8712010
    [Abstract] [Full Text] [Related]

  • 3. [Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22].
    Yang YX, Zhu L, He X, Bao DY, Bao X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):68-70. PubMed ID: 14981819
    [Abstract] [Full Text] [Related]

  • 4. [Study on mitoxantrone albumin microspheres for liver targeting].
    Zhang ZR, Qian WJ.
    Yao Xue Xue Bao; 1997 Jan; 32(1):72-8. PubMed ID: 11243225
    [Abstract] [Full Text] [Related]

  • 5. [Study on the mitoxantrone ethylcellulose microspheres for liver artery embolization].
    Zhang ZR, Wang D, Liao FY, Liao GT.
    Yao Xue Xue Bao; 1996 Jan; 31(8):626-31. PubMed ID: 9772711
    [Abstract] [Full Text] [Related]

  • 6. [An observation of the anticarcinogenic effect of mitoxantrone-polybutylcyanoacrylate-nanosperes].
    Zhang Z, Liao G, Hou S, Bai S, Zhang X.
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):381-4. PubMed ID: 8150436
    [Abstract] [Full Text] [Related]

  • 7. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM, Yang XY, Deng SH, Xu W, Gao HQ.
    Chin Med J (Engl); 2007 Aug 05; 120(15):1336-42. PubMed ID: 17711740
    [Abstract] [Full Text] [Related]

  • 8. [Study on the mitoxantrone carboxymethyl starch microspheres for hepatic artery chemoembolization].
    Zhang Z, Wei Z, Wang L, Liao F.
    Yao Xue Xue Bao; 1998 Oct 05; 33(10):772-7. PubMed ID: 12016932
    [Abstract] [Full Text] [Related]

  • 9. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles].
    Zhang ZR, Lu W.
    Yao Xue Xue Bao; 1997 Oct 05; 32(3):222-7. PubMed ID: 11327027
    [Abstract] [Full Text] [Related]

  • 10. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
    Sun X, Wu F, Lu W, Zhang ZR.
    Pharmazie; 2004 Oct 05; 59(10):791-4. PubMed ID: 15544059
    [Abstract] [Full Text] [Related]

  • 11. Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles.
    Zhang ZR, He Q, Liao GT, Bai SH.
    World J Gastroenterol; 1999 Dec 05; 5(6):511-514. PubMed ID: 11819500
    [Abstract] [Full Text] [Related]

  • 12. [Studies on lung targeting gelatin microspheres of mitoxantrone].
    Wang JH, Lu B, Xu PL, Bao DY, Zhang ZR.
    Yao Xue Xue Bao; 1995 Dec 05; 30(7):549-55. PubMed ID: 7484159
    [Abstract] [Full Text] [Related]

  • 13. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF, Wang X, Wang C, Zhao K, Liu XJ, Shen HJ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct 05; 31(5):732-6, 741. PubMed ID: 17062941
    [Abstract] [Full Text] [Related]

  • 14. [Acute toxicity of liver targeting mitoxantrone-nanospheres].
    Zhang Z, Liao G.
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar 05; 26(1):38-40. PubMed ID: 7657335
    [Abstract] [Full Text] [Related]

  • 15. Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
    Reszka R, Beck P, Fichtner I, Hentschel M, Richter J, Kreuter J.
    J Pharmacol Exp Ther; 1997 Jan 05; 280(1):232-7. PubMed ID: 8996201
    [Abstract] [Full Text] [Related]

  • 16. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
    Xi-Xiao Y, Jan-Hai C, Shi-Ting L, Dan G, Xv-Xin Z.
    Regul Toxicol Pharmacol; 2006 Dec 05; 46(3):211-7. PubMed ID: 17010489
    [Abstract] [Full Text] [Related]

  • 17. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y, Xu J, Lin Y, Yu H, Gong T, Li Y, Zhang Z.
    J Biomed Mater Res A; 2008 Nov 05; 87(2):515-23. PubMed ID: 18186066
    [Abstract] [Full Text] [Related]

  • 18. [Study on liver targeted valaciclovir polybutylcyanoacrylate nanoparticles].
    Zhang Z, He Q.
    Yao Xue Xue Bao; 1998 Sep 05; 33(9):702-6. PubMed ID: 12016876
    [Abstract] [Full Text] [Related]

  • 19. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: Tissue distribution and pharmacodynamics.
    Lu B, Xiong SB, Yang H, Yin XD, Zhao RB.
    Int J Pharm; 2006 Jan 13; 307(2):175-81. PubMed ID: 16314056
    [Abstract] [Full Text] [Related]

  • 20. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF, Zhang YD, Shen HJ, Zeng S, Wang X, Wang C, Le Y, Shen H.
    Chin Med J (Engl); 2006 Aug 05; 119(15):1287-93. PubMed ID: 16919188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.